HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margarete Schön Selected Research

1- O- octadecyl- 2- O- (2- inositolylethyl)- glycero- 3- phosphatidylcholine

10/2014Inositoylated platelet-activating factor (Ino-C2-PAF) modulates dynamic lymphocyte-endothelial cell interactions and alleviates psoriasis-like skin inflammation in two complementary mouse models.
2/2014Inositol-C2-PAF down-regulates components of the antigen presentation machinery in a 2D-model of epidermal inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Margarete Schön Research Topics

Disease

14Neoplasms (Cancer)
02/2019 - 08/2003
11Melanoma (Melanoma, Malignant)
02/2019 - 06/2002
8Neoplasm Metastasis (Metastasis)
02/2019 - 05/2004
7Inflammation (Inflammations)
04/2016 - 04/2002
5Psoriasis (Pustulosis Palmaris et Plantaris)
04/2016 - 04/2002
3Skin Neoplasms (Skin Cancer)
02/2006 - 08/2003
2Actinic Keratosis
01/2016 - 08/2003
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
02/2019
1Parkinson Disease (Parkinson's Disease)
01/2017
1Skin Diseases (Skin Disease)
10/2014
1Disease Progression
08/2014
1Allergic Contact Dermatitis
02/2014
1Atopic Dermatitis (Atopic Eczema)
02/2014
1Experimental Melanoma
02/2012
1Prostatic Neoplasms (Prostate Cancer)
11/2009
1Carcinogenesis
09/2007
1Necrosis
08/2003

Drug/Important Bio-Agent (IBA)

5Imiquimod (Aldara)FDA LinkGeneric
01/2007 - 08/2003
3LigandsIBA
01/2018 - 08/2003
3CytokinesIBA
02/2014 - 08/2003
2IntegrinsIBA
01/2018 - 04/2016
2Proteins (Proteins, Gene)FDA Link
01/2017 - 02/2010
2AntibodiesIBA
04/2016 - 08/2005
21- O- octadecyl- 2- O- (2- inositolylethyl)- glycero- 3- phosphatidylcholineIBA
10/2014 - 02/2014
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2014 - 08/2003
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2012 - 06/2008
2Toll-Like Receptors (Toll-Like Receptor)IBA
02/2012 - 06/2006
2Green Fluorescent ProteinsIBA
02/2012 - 02/2010
2NF-kappa B (NF-kB)IBA
04/2010 - 06/2008
2Cytostatic AgentsIBA
04/2010 - 06/2008
2SelectinsIBA
04/2006 - 04/2002
2Death Domain ReceptorsIBA
05/2004 - 08/2003
1laquinimodIBA
02/2019
1CD226 antigenIBA
02/2019
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2018
1SynucleinsIBA
01/2017
1pyrazoleIBA
01/2017
13- (1,3- benzodioxol- 5- yl)- 5- (3- bromophenyl)- 1H- pyrazoleIBA
01/2017
1diphenyl (biphenyl)IBA
01/2017
1Blocking AntibodiesIBA
04/2016
1MicroRNAs (MicroRNA)IBA
01/2016
13-ingenyl angelateIBA
01/2016
1Platelet Activating FactorIBA
10/2014
1Phosphotransferases (Kinase)IBA
08/2014
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
08/2014
1copanlisibIBA
08/2014
1Phospholipids (Phosphatides)FDA LinkGeneric
02/2014
1macrophage stimulatory lipopeptide 2IBA
02/2012
1Proteasome Endopeptidase Complex (Proteasome)IBA
04/2010
1P-SelectinIBA
02/2010
1Immunoglobulin Fab FragmentsIBA
02/2010
1AndrogensIBA
11/2009
1Messenger RNA (mRNA)IBA
11/2009
1AgarIBA
06/2008
1CamptothecinIBA
06/2008
1ErbB Receptors (EGF Receptor)IBA
09/2007
1Peptide Hydrolases (Proteases)FDA Link
09/2007
1Transforming Growth Factors (Transforming Growth Factor)IBA
09/2007
1Proteinase-Activated ReceptorsIBA
09/2007
1Mitogen-Activated Protein Kinase 3IBA
09/2007
1NucleosidesIBA
01/2007
1Purinergic P1 Receptors (Adenosine Receptor)IBA
06/2006
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
08/2005
1Laminin ReceptorsIBA
07/2004
1Cell Adhesion MoleculesIBA
07/2004
1Laminin (Merosin)IBA
07/2004
1Immunoglobulins (Immunoglobulin)IBA
07/2004
1Immunologic Factors (Immunomodulators)IBA
05/2004
1CaspasesIBA
08/2003
1Cytochromes c (Cytochrome c)IBA
08/2003
1MART-1 AntigenIBA
06/2002
1efomycine MIBA
04/2002

Therapy/Procedure

4Therapeutics
10/2014 - 04/2006
3Drug Therapy (Chemotherapy)
08/2014 - 06/2008
2Heterologous Transplantation (Xenotransplantation)
08/2014 - 01/2011